Are There Biological Markers for Wear or Corrosion? A Systematic Review

Clinical Orthopaedics and Related Research

Volumn 472, Issue 12, 2014, Pages 3728-3739

  Sumner, D Rick ^a   Ross, Ryan ^a   Purdue, Ed ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTHROPLASTY; BIOMECHANICS; BLOOD; CORROSION; DIAGNOSIS; DIAGNOSTIC IMAGING; ETIOLOGY; HUMAN; JOINT; JOINT PROSTHESIS; MECHANICAL STRESS; OSTEOLYSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS; PROSTHESIS FAILURE; RISK FACTOR; SURGERY; TREATMENT OUTCOME;

ARTHROPLASTY, REPLACEMENT; BIOLOGICAL MARKERS; BIOMECHANICAL PHENOMENA; CORROSION; DIAGNOSTIC IMAGING; HUMANS; JOINT PROSTHESIS; JOINTS; OSTEOLYSIS; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RISK FACTORS; STRESS, MECHANICAL; TREATMENT OUTCOME;

EID: 84896550222     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-014-3580-3     Document Type: Article

References (36)

1. Anonymous. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89–95.
2. Antoniou J, Huk O, Zukor D, Eyre D, Alini M. Collagen crosslinked N-telopeptides as markers for evaluating particulate osteolysis: a preliminary study. J Orthop Res. 2000;18:64–67.
3. Atkins GJ, Haynes DR, Howie DW, Findlay DM. Role of polyethylene particles in peri-prosthetic osteolysis: a review. World J Orthop. 2011;2:93–101.
4. Bauer TW, Shanbhag AS. Are there biological markers of wear? J Am Acad Orthop Surg. 2008;16(Suppl 1):S68–S71.
5. Del Buono A, Denaro V, Maffulli N. Genetic susceptibility to aseptic loosening following total hip arthroplasty: a systematic review. Br Med Bull. 2012;101:39–55.
6. Fiorito S, Magrini L, Goalard C. Pro-inflammatory and anti-inflammatory circulating cytokines and periprosthetic osteolysis. J Bone Joint Surg Br. 2003;85:1202–1206.
7. Gil-Albarova J, Lacleriga A, Barrios C, Canadell J. Lymphocyte response to polymethylmethacrylate in loose total hip prostheses. J Bone Joint Surg Br. 1992;74:825–830.
8. Granchi D, Pellacani A, Spina M, Cenni E, Savarino LM, Baldini N, Giunti A. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis. J Bone Joint Surg Am. 2006;88:1501–1509.
9. Hallab NJ, Jacobs JJ. Biologic effects of implant debris. Bull NYU Hosp Jt Dis. 2009;67:182–188.
10. He T, Wu W, Huang Y, Zhang X, Tang T, Dai K. Multiple biomarkers analysis for the early detection of prosthetic aseptic loosening of hip arthroplasty. Int Orthop. 2013;37:1025–1031.
11. Hernigou P, Intrator L, Bahrami T, Bensussan A, Farcet JP. Interleukin-6 in the blood of patients with total hip arthroplasty without loosening. Clin Orthop Relat Res. 1999;366:147–154.
12. Huang W, Sowa G. Biomarker development for musculoskeletal diseases. PM R. 2011;3:S39–S44.
13. Hundric-Haspl Z, Pecina M, Haspl M, Tomicic M, Jukic I. Plasma cytokines as markers of aseptic prosthesis loosening. Clin Orthop Relat Res. 2006;453:299–304.
14. Kauther MD, Zimmermann C, Bachmann H, Broecker-Preuss M, Hilken G, von Knoch M, Wedemeyer C. Biochemical markers of particle induced osteolysis in C57BL/6 mice. Clin Chem Lab Med. 2010;48:1641–1646.
15. Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.
16. Landgraeber S, Loer F, Heep H, Classen T, Grabellus F, Totsch M, von Knoch M. Tartrate-resistant acid phosphatase 5b and C-terminal telopeptides of type I collagen as markers for diagnosis of aseptic loosening after total hip replacement. Arch Orthop Trauma Surg. 2010;130:441–445.
17. Li MG, Thorsen K, Nilsson KG. Increased bone turnover as reflected by biochemical markers in patients with potentially unstable fixation of the tibial component. Arch Orthop Trauma Surg. 2004;124:404–409.
18. Liu S, Virdi AS, Sena K, Hughes WF, Sumner DR. Bone turnover markers correlate with implant fixation in a rat model using LPS doped particles to induce implant loosening. J Biomed Mater Res A. 2012;100:918–928.
19. Mertens MT, Singh JA. Biomarkers in arthroplasty: a systematic review. Open Orthop J. 2011;5:92–105.
20. Moreschini O, Fiorito S, Magrini L, Margheritini F, Romanini L. Markers of connective tissue activation in aseptic hip prosthetic loosening. J Arthroplasty. 1997;12:695–703.
21. Nich C, Langlois J, Marchadier A, Vidal C, Cohen-Solal M, Petite H, Hamadouche M. Oestrogen deficiency modulates particle-induced osteolysis. Arthritis Res Ther. 2011;13:R100.
22. Nivbrant B, Karlsson K, Karrholm J. Cytokine levels in synovial fluid from hips with well-functioning or loose prostheses. J Bone Joint Surg Br. 1999;81:163–166.
23. Ollivere B, Wimhurst JA, Clark IM, Donell ST. Current concepts in osteolysis. J Bone Joint Surg Br. 2012;94:10–15.
24. Pellengahr C, Mayer W, Durr HR, Maier M, Muller P, Veihelmann A, Zysk S, Jansson V, Refior HJ. The value of desoxypyridinoline in the diagnostics of loosened arthroplasty. Arch Orthop Trauma Surg. 2001;121:205–206.
25. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Relat Res. 2007;454:251–261.
26. Roato I, Caldo D, D’Amico L, D’Amelio P, Godio L, Patane S, Astore F, Grappiolo G, Boggio M, Scagnelli R, Molfetta L, Ferracini R. Osteoclastogenesis in peripheral blood mononuclear cell cultures of periprosthetic osteolysis patients and the phenotype of T cells localized in periprosthetic tissues. Biomaterials. 2010;31:7519–7525.
27. Ross RD, Virdi AS, Liu S, Sena K, Sumner DR. Particle-induced osteolysis is not accompanied by systemic remodeling but is reflected by systemic bone biomarkers. J Orthop Res. 2014 Mar 6 [Epub ahead of print].
28. Savarino L, Avnet S, Greco M, Giunti A, Baldini N. Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: a cohort study. J Orthop Res. 2010;28:887–892.
29. Savarino L, Granchi D, Cenni E, Baldini N, Greco M, Giunti A. Systemic cross-linked N-terminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty. J Bone Joint Surg Br. 2005;87:571–576.
30. Schneider U, Breusch SJ, Termath S, Thomsen M, Brocai DRC, Niethard F-U, Kasperk C. Increased urinary crosslink levels in aseptic loosening of total hip arthroplasty. J Arthroplasty. 1998;13:687–692.
31. Streich NA, Breusch SJ, Schneider U. Serum levels of interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and elastase in aseptic prosthetic loosening. Int Orthop. 2003;27:267–271.
32. Streich NA, Gotterbarm T, Jung M, Schneider U, Heisel C. Biochemical markers of bone turnover in aseptic loosening in hip arthroplasty. Int Orthop. 2009;33:77–82.
33. Tanaka R, Yasunaga Y, Hisatome T, Yamasaki T, Iwamori H, Ochi M. Serum interleukin 8 levels correlate with synovial fluid levels in patients with aseptic loosening of hip prosthesis. J Arthroplasty. 2005;20:1049–1054.
34. von Schewelov T, Carlsson A, Dahlberg L. Cross-linked N-telopeptide of type I collagen (NTx) in urine as a predictor of periprosthetic osteolysis. J Orthop Res. 2006;24:1342–1348.
35. Wilkinson JM, Hamer AJ, Rogers A, Stockley I, Eastell R. Bone mineral density and biochemical markers of bone turnover in aseptic loosening after total hip arthroplasty. J Orthop Res. 2003;21:691–696.
36. Wu W, Zhang X, Zhang C, Tang T, Ren W, Dai K. Expansion of CD14+CD16+ peripheral monocytes among patients with aseptic loosening. Inflamm Res. 2009;58:561–570.